NEU 2.37% $19.39 neuren pharmaceuticals limited

ANAVEX MEETS ENDPOINTS PHASE2 RETT, page-109

  1. 2,832 Posts.
    lightbulb Created with Sketch. 593
    I'd be astounded if BP wasn't beating down Neuren's door right now seeking to acquire them.


 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.